
NCGC 00067819
CAS No. 847163-23-9
NCGC 00067819( NCGC00067819 )
Catalog No. M16148 CAS No. 847163-23-9
NCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNCGC 00067819
-
NoteResearch use only, not for human use.
-
Brief DescriptionNCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay.
-
DescriptionNCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay; potentiates cAMP production induced by NKH 477.
-
In Vitro——
-
In Vivo——
-
SynonymsNCGC00067819
-
PathwayNuclear Receptor/Transcription Factor
-
TargetCREB/CBP
-
RecptorCREB/CBP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number847163-23-9
-
Formula Weight346.408
-
Molecular FormulaC19H14N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=NC2=C(C(=N1)SCC3=NC4=CC=CC=C4N3)OC5=CC=CC=C52
-
Chemical Name4-(1H-benzimidazol-2-ylmethylsulfanyl)-2-methyl-[1]benzofuro[3,2-d]pyrimidine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xia M, et al. Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2412-7.
molnova catalog



related products
-
NCGC 00067819
NCGC 00067819 is a small molecule compound that potentiates CREB signaling with EC50 of 16 nM in the primary screen and 79 nM in the CHO CRE-β-lactamase confirmation assay.
-
Naphthol AS-E
A cell-permeable inhibitor of the KIX-KID interaction and CREB-mediated gene transcription (IC50=2.26 uM).
-
KG-501
A small-molecule antagonist of CREB-CBP interaction, inhibits the cAMP-dependent activation of cellular genes via CREB.